[Remimazolam-Update on basic pharmacologic principles and clinical potential].

Scheckenbach, Vera; Drexler, Berthold

[Remimazolam-Update on basic pharmacologic principles and clinical potential]. / Remimazolam Update zu Grundlagen und klinischem Potenzial.

Scheckenbach, Vera; Drexler, Berthold.

Afiliación

Scheckenbach V; Universitätsklinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Deutschland.
Drexler B; Universitätsklinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Deutschland. berthold.drexler@uni-tuebingen.de.

Anaesthesiologie ; 73(9): 617-626, 2024 Sep.

Article en De | MEDLINE | ID: mdl-39158735

ABSTRACT

ABSTRACT

In recent years the still relatively new short-acting benzodiazepine remimazolam has been approved and clinically implemented in several countries and regions. Remimazolam is also now approved in the EU and the market launch in Germany is expected in the not too distant future. This is therefore a good point in time to summarize the current evidence for various areas of application, including general anesthesia, sedation and intensive care medicine as well as different dosing schemes.

Asunto(s)

Benzodiazepinas; Hipnóticos y Sedantes; Humanos; Benzodiazepinas/farmacología; Benzodiazepinas/uso terapéutico; Hipnóticos y Sedantes/farmacología; Hipnóticos y Sedantes/uso terapéutico; Cuidados Críticos/métodos

Palabras clave

Benzodiazepine; Dosing schemes; Remimazolam; Sedation; Short-acting hypnotic

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Benzodiazepinas / Hipnóticos y Sedantes Límite: Humans Idioma: De Revista: Anaesthesiologie Año: 2024 Tipo del documento: Article Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google